Shu Wang

4.2k total citations
69 papers, 3.3k citations indexed

About

Shu Wang is a scholar working on Molecular Biology, Oncology and Immunology. According to data from OpenAlex, Shu Wang has authored 69 papers receiving a total of 3.3k indexed citations (citations by other indexed papers that have themselves been cited), including 40 papers in Molecular Biology, 25 papers in Oncology and 23 papers in Immunology. Recurrent topics in Shu Wang's work include CAR-T cell therapy research (22 papers), RNA Interference and Gene Delivery (20 papers) and Immune Cell Function and Interaction (20 papers). Shu Wang is often cited by papers focused on CAR-T cell therapy research (22 papers), RNA Interference and Gene Delivery (20 papers) and Immune Cell Function and Interaction (20 papers). Shu Wang collaborates with scholars based in Singapore, China and United States. Shu Wang's co-authors include Seong Loong Lo, Seeram Ramakrishna, Shujun Gao, Yu Yang Ng, Jieming Zeng, Chunxiao Wu, Johan Chin-Kang Tay, Kam W. Leong, T. B. Bini and Xiaoyun Xu and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Advanced Materials and Blood.

In The Last Decade

Shu Wang

68 papers receiving 3.2k citations

Peers

Countries citing papers authored by Shu Wang

Since Specialization

Citations

This map shows the geographic impact of Shu Wang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shu Wang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shu Wang more than expected).

Fields of papers citing papers by Shu Wang

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Shu Wang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shu Wang. The network helps show where Shu Wang may publish in the future.

Co-authorship network of co-authors of Shu Wang

This figure shows the co-authorship network connecting the top 25 collaborators of Shu Wang. A scholar is included among the top collaborators of Shu Wang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shu Wang. Shu Wang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	NKG2D CAR-NK adoptive cellular immunotherapy combined with or without PD-1 blockade in the treatment of patients with metastatic colorectal cancer: an exploratory study 2025 ·Cancer Immunology Immunotherapy ·(unknown), Бин Ли, (unknown), Hangyu Zhang, Yang Gao, Zhimin Du, Xiaomeng Dai, Xuanwen Bao, Xudong Zhu, Zhou Tong, Dongxue Hu, Lulu Liu, Yi Zheng, Peng Zhao, Shu Wang, Weijia Fang	1
2	Aloperine Ameliorates Acetaminophen‐Induced Acute Liver Injury through HMGB1/TLR4/NF‐κB and NLRP3/Inflammasome Pathway 2024 ·Mediators of Inflammation ·Hui Chen, Shu Wang, Qiuyue Chen, Wen Yu, Hao Nie, Lian Liu, Bing Zheng, (unknown)	4
3	Non-Conventional Allogeneic Anti-BCMA Chimeric Antigen Receptor-Based Immune Cell Therapies for Multiple Myeloma Treatment 2023 ·Cancers ·(unknown), (unknown), Xi Zhang, Zhiyuan Gong, Shu Wang	12
4	Dual CAR-T cells to treat cancers co-expressing NKG2D and PD1 ligands in xenograft models of peritoneal metastasis 2022 ·Cancer Immunology Immunotherapy ·Guangyi Jiang, Yu Yang Ng, Johan Chin-Kang Tay, (unknown), Lin Xiao, Shu Wang, Jianqing Zhu	22
5	Manufacturing NKG2D CAR-T cells with piggyBac transposon vectors and K562 artificial antigen-presenting cells 2021 ·Molecular Therapy — Methods & Clinical Development ·Johan Chin-Kang Tay, (unknown), (unknown), Yu Yang Ng, Qiang Li, (unknown), Chang Zhang, Jianqing Zhu, Xuehu Xu, Shu Wang	20
6	Spatial Multi-Objective Land Use Optimization toward Livability Based on Boundary-Based Genetic Algorithm: A Case Study in Singapore 2020 ·ISPRS International Journal of Geo-Information ·Kai Cao, (unknown), Shu Wang, (unknown), Wenting Zhang, Qiang Meng, Bo Huang	26
7	CXCR1 Expression to Improve Anti-Cancer Efficacy of Intravenously Injected CAR-NK Cells in Mice with Peritoneal Xenografts 2019 ·Molecular Therapy — Oncolytics ·Yu Yang Ng, Johan Chin-Kang Tay, Shu Wang	127
8	Opposite Effects of Coinjection and Distant Injection of Mesenchymal Stem Cells on Breast Tumor Cell Growth 2016 ·Stem Cells Translational Medicine ·Huilin Zheng, (unknown), Jiaying Shen, Liang Xu, Shu Wang, Yang-Xin Fu, Weimin Fan	23
9	Co-Expansion of Cytokine-Induced Killer Cells and Vγ9Vδ2 T Cells for CAR T-Cell Therapy 2016 ·PLoS ONE ·Shouhui Du, Qiang Li, Can Chen, (unknown), (unknown), (unknown), Xuehu Xu, Shu Wang	45
10	Antigenically Modified Human Pluripotent Stem Cells Generate Antigen-Presenting Dendritic Cells 2015 ·Scientific Reports ·Jieming Zeng, Chunxiao Wu, Shu Wang	16
11	Human iPS cell-derived fibroblast-like cells as feeder layers for iPS cell derivation and expansion 2015 ·Journal of Bioscience and Bioengineering ·Shouhui Du, Johan Chin-Kang Tay, Can Chen, (unknown), (unknown), Qiang Li, Shu Wang	8
12	Baculovirus: an Insect-derived Vector for Diverse Gene Transfer Applications 2013 ·Molecular Therapy ·Kari J. Airenne, Yu‐Chen Hu, Thomas A. Kost, Richard H. Smith, Robert M. Kotin, Chikako Ono, Yoshiharu Matsuura, Shu Wang, Seppo Ylä‐Herttuala	134
13	Microfibers Fabricated by Non‐Covalent Assembly of Peptide and DNA for Viral Vector Encapsulation and Cancer Therapy 2012 ·Advanced Materials ·Jingye Yang, Ghayathri Balasundaram, (unknown), (unknown), Jun Xue, Jianxing Song, Andrew C.A. Wan, Jackie Y. Ying, Shu Wang	16
14	High-efficiency Transient Transduction of Human Embryonic Stem Cell–derived Neurons With Baculoviral Vectors 2009 ·Molecular Therapy ·Jieming Zeng, Juan Du, (unknown), (unknown), Chunxiao Wu, Shu Wang	30
15	High Mobility Group Box2 Promoter-controlled Suicide Gene Expression Enables Targeted Glioblastoma Treatment 2009 ·Molecular Therapy ·Poonam Balani, Jérôme Boulaire, Ying Zhao, Jieming Zeng, (unknown), Shu Wang	36
16	Establishment of medakafish as a model for stem cell-based gene therapy: Efficient gene delivery and potential chromosomal integration by baculoviral vectors 2009 ·Experimental Cell Research ·Yan Yan, Juan Du, (unknown), Meisheng Yi, Mingyou Li, Shu Wang, Chang Ming Li, Yunhan Hong	24
17	Gene expression profiling to define host response to baculoviral transduction in the brain 2009 ·Journal of Neurochemistry ·Jérôme Boulaire, Ying Zhao, Shu Wang	21
18	A peptide-based carrier for intracellular delivery of proteins into malignant glial cells in vitro 2008 ·Journal of Controlled Release ·Chunxiao Wu, Seong Loong Lo, Jérôme Boulaire, Michelle Hong, (unknown), (unknown), Shu Wang	36
19	A synthetic peptide containing loop 4 of nerve growth factor for targeted gene delivery 2004 ·The Journal of Gene Medicine ·Jieming Zeng, Heng‐Phon Too, (unknown), (unknown), Shu Wang	23
20	Peripheral nerve regeneration by microbraided poly(L‐lactide‐co‐glycolide) biodegradable polymer fibers 2003 ·Journal of Biomedical Materials Research Part A ·T. B. Bini, Shujun Gao, Xiaoyun Xu, Shu Wang, Seeram Ramakrishna, Kam W. Leong	135

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact